Strength and agility in exploiting, protecting and enforcing intellectual property rights is business-critical. Our full-service intellectual property practice combines proven first-chair trial lawyers with true technical specialists to defend our clients’ IP interests through:
Our IP litigators have handled hundreds of complex litigation matters across a diverse range of industry sectors, including most notably life sciences, telecommunications, computer systems, media and entertainment, biotech, consumer products, oil and gas, cosmetics, and food and beverage.
Our patent trial lawyers are extremely capable in obtaining the best results for our clients and are not afraid to litigate in the most complicated of cases. For many clients, the at-risk product revenues were in the billions of dollars per case.
Our IP practice has established a reputation as a go-to firm for IP appellate work. Our litigation teams make concerted efforts to include, where appropriate, appellate practitioners before, during and after trial to ensure the best record and the best results for the client.
In trademark and copyright litigation, our lawyers have represented clients in trials and preliminary injunction hearing, practiced in federal courts, the USPTO, TTAB and ITC, and participated in ICANN domain name arbitrations.
Our media and entertainment practice is right at the cutting edge of digital media and traditional media. Our team has particular experience in litigating copyright infringement and antitrust/rate-setting claims in cases involving the distribution of audio and audio-visual media content.
The majority of the team’s patent professionals hold technical degrees, with many having industry experience as well.
February 3, 2021
Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling
Managing IP Handbook, 2020
Chambers USA, 2020
Legal 500 US, 2020
World Trademark Review 1000, 2020
Intellectual Asset Management, 2020
Benchmark Litigation, 2020
US News & World Report, 2020
Chambers USA, 2017
December 1, 2020
Aaron's Completes Spin-Off Transaction